-
Cannabis Brands Brace For Post-Pandemic World, COVID-Induced Challenges Ahead
Thursday, December 24, 2020 - 9:37am | 986The COVID-19 pandemic continues to rear its ugly head, with Covid-19 cases in the US pass 18 million. Over 300,00 deaths have been attributed to COVID-19 in the United States thus far. A vaccine from Pfizer Inc. (NYSE: PFE) and German partner BioNTech SE - ADR (NASDAQ: BNTX) is currently being...
-
Tuesday's Market Minute: The Post-Pandemic Push
Tuesday, November 10, 2020 - 12:01pm | 482Monday’s market action in the four major indices identified a clear divide between the winners and losers at the eventual end of the pandemic: big tech stands to lose and the Blue Chips and small-cap names stand to gain. That was evident in where the indices closed on Monday after Pfizer Inc...
-
Pfizer Surges But Zoom, Netflix, Amazon, Other "Stay-at-Home" Stocks Pressured On Vaccine News
Monday, November 9, 2020 - 11:12am | 2077It’s hard to find a superlative that captures all the drama this morning. About the only thing that could overshadow relief about getting the election behind us is this amazing vaccine news from Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX). Their vaccine...
-
Monday's Market Minute: Equities Surge On Positive Vaccine News
Monday, November 9, 2020 - 10:57am | 303Equity index futures are charging right out the gate this week on positive news about Pfizer Inc.’s (NYSE: PFE) COVID-19 vaccine. Small-caps, in particular, are seeing the most strength, with Russell 2000 futures trading limit up for a 7% gain. S&P and Dow futures are also looking strong...
-
Market Structure Expert Shares One Simple Trading Rule With An 83% Success Rate
Wednesday, September 2, 2020 - 2:17pm | 886The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. This special presentation from Market Structure EDGE comes from the Benzinga Options Boot Camp, which took place on August 28, 2020. Any...
-
#PreMarket Primer: Tuesday, April 29: US Steps Up Sanctions Against Russia
Tuesday, April 29, 2014 - 7:08am | 1259In an effort to force Moscow to backtrack on its actions in Ukraine, the US and Europe have imposed more economic sanctions against Russia. The sanctions, designed to target government individuals and businesses linked to President Vladimir Putin, were not as strict as some were expecting which...
-
Pharmaceutical Stocks For Income, Value And Growth Investors
Thursday, April 17, 2014 - 10:12am | 357Pharmaceutical stocks are excellent holdings in times of a downturn. Health care is the largest component of the American economy, about one-sixth the gross domestic product. For income, value, and growth investors, respectively, there are GlaxoSmithKline (NYSE: GSK), Pfizer (NYSE: PFE), and...
-
Three Dow Components Booted Tuesday, But Don't Read Too Much Into The Decision (AA, BAC, HPQ)
Tuesday, September 10, 2013 - 3:45pm | 646In a move described as the largest in nearly a decade, The Wall Street Journal reported Tuesday that Alcoa (NYSE: AA), Hewlett-Packard (NYSE: HPQ), and Bank of America (NYSE: BAC) would be dropped from the Dow Industrials at the close of trading September 20. Goldman Sachs (NYSE: GS), Nike (...
-
Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues (LLY)
Tuesday, July 16, 2013 - 11:30am | 536Eli Lilly & Co. (NYSE: LLY) planned to go back to the drawing board with its new experimental Alzheimer’s drug, according Bloomberg. The drug, solanezumab, which was not successful with advanced Alzheimer’s patients, will be tested in patients who show signs of early stages of the disease...
-
Drug Company Profits Set to Increase from Additions to DSM-5 (LLY, NVS, PFE)
Thursday, June 6, 2013 - 8:59am | 612It’s a simple matter of math. The more diseases there are to treat, the more profit there is to be made – by drug companies that produce the medicines designed to treat those diseases. The Wall Street Journal reported Wednesday that the 5th edition of the Diagnostic and Statistic Manual of...
-
Bank Of America Ups PT To $25 On PFE
Monday, May 16, 2011 - 7:49am | 138Bank of America has raised its price target on Pfizer Inc. (NYSE: OFE) to $25 as it reiterates a Buy rating on the stock. Says Bank of America, in its report, “With each of the 4 US Major Pharma stocks beating Q1 results and investors beginning to warm up to our "the world is not ending" valuation...
-
Morgan Stanley Reports Early Generic Lipitor Risk Explained And Quantified For Pfizer
Monday, March 21, 2011 - 7:17am | 106In a report published by Morgan Stanley, Pfizer's (NYSE: PFE) early generic Lipitor risk is explained and quantified. Morgan Stanley said that Mylan filed a lawsuit to compel FDA to act on generic Lipitor. “Mylan believes that FDA should deny Ranbaxy's exclusivity if FDA invoked its Application...
-
FDA Approves Pfizer (NYSE: PFE) Prevnar 13 Bacteria Vaccine
Wednesday, February 24, 2010 - 1:48pm | 101The U.S. Food and Drug Administration approved the Pfizer Inc. (NYSE: PFE) vaccine Prevnar 13 as a follow up vaccine of Prevnar. The vaccines protect children from the age of 6 weeks to 5 years old from bacteria that can cause serious illnesses, such as as meningitis, acute ear infections,...